trending Market Intelligence /marketintelligence/en/news-insights/trending/zbsgwxc-4xstf7lsv4y6gw2 content esgSubNav
In This List

Oxford Immunotec appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Oxford Immunotec appoints board member

Oxford Immunotec Global PLC appointed Mark Klausner to the board.

Klausner is the co-founder and managing partner of Westwicke Partners, a capital markets advisory and investor relations firm focused on the healthcare industry.

Oxford Immunotec is a U.K.-based diagnostics company.